Qu Biologics Cleared to Proceed with Crohn’s Disease Clinical Trial, DSMC Says
Crohn's Disease, News
Qu Biologics, Inc., a biotech company that specializes in formulating Site Specific Immunomodulators (SSI) for the restoration of normal immune system function, has just announced that a Data Safety Monitoring Committee ... Read more